Status:
TERMINATED
Effect of Orofacial Myofunctional Therapy on Mouth Air Leak in Patients With Sleep Apnea Treated With CPAP
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
OSA
Apnea+Hypopnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To verify the effect of orofacial myofunctional therapy in patients with OSA during the use of CPAP with a nasal mask, on the frequency and leak flow. In addition, the impact on mouth opening frequenc...
Detailed Description
The use of continuous positive airway pressure (CPAP) with a nasal mask during sleep is the gold standard treatment for moderate to severe obstructive sleep apnea (OSA). However, low adherence to CPAP...
Eligibility Criteria
Inclusion
- • Diagnosis of OSA (AHI\>15 events/h) on use of CPAP (\>3 months) with suspect mouth leak as observed by the complaint of morning dry mouth and or CPAP report indicating an excessive air leak
Exclusion
- Central Sleep Apnea, oxygen dependent, COPD.
Key Trial Info
Start Date :
July 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05432908
Start Date
July 28 2017
End Date
July 1 2021
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundação Zerbini - Instituto do Coração (InCor)
São Paulo, São Paulo, Brazil, 054039000